BC
Brian Cheng JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
66.7%
Neutral
16.7%
Negative
16.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $23 |
23%
upside
| 1 | +25% |
0
%
| 16 Oct ‘25 4 days ago |
|
|
|
Underweight
Downgraded
| – | – | 2 | +13% |
0
%
| 10 Oct ‘25 10 days ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | -3.2% |
0
%
| 10 Oct ‘25 10 days ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +58% |
0
%
| 2 Oct ‘25 18 days ago |
|
|
|
Overweight
Maintained
| $33 |
73%
upside
| 2 | +14% |
0
%
| 30 Sep ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $47 |
11%
upside
| 1 | +23% |
0
%
| 26 Sep ‘25 24 days ago |
|
|
|
Overweight
Maintained
| $20 |
11%
upside
| 1 | +17% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $70 |
5%
downside
| 1 | +25% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Neutral
Upgraded
| – | – | 1 | – |
–
| 15 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $22 |
37%
upside
| 1 | +55% |
0
%
| 7 Aug ‘25 2 months ago |
|